ABL Diagnostics and CDL Pharma secure a multi year renewal of clinical services with a long standing Pharma partner
The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s intra‑portfolio strategy ABL Diagnostics SA (EPA:ABLD – ISIN : FR001400AHX6) WOIPPY, MOSELLE, FRANCE, February 18, 2026 / …